Pay in 4 interest-free payments of $6.13 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
A 2024 KFF study found Medicaid coverage could benefit 40% of adults and 26% of children with obesity, forcing policymakers to weigh cost, equity and long-term health outcomes as demand grows and new uses emerge
Patients should stay informed about current FDA guidance and confirm that their telehealth platform and pharmacy are operating in compliance with current federal and state compounding regulations
Its an excellent option for those combining weight loss with physical activity
Many clients find it convenient to take their injection in the evening, as it allows them to relax and not have to worry about it during their busy daytime hours
A study by the Institute of Clinical and Economic Review showed that in order for these medications to be priced effectively such that the risk of cardiovascular disease was higher than the cost of these weight loss drugs, they would need to be priced annually somewhere between $7,500 and $9,800 per patient per year
Retatrutide works like other weight loss and type 2 diabetes medications, but what makes it different is that it can target three receptors (triple agonist) at once: Gastric inhibitory polypeptide receptor (GIP) Glucagon-like peptide-1 receptor (GLP-1) Glucagon receptors (GCG) This unique triple-action may make it more effective than GLP-1 and GLP-1/GIP medications
